News

Q2 Holdings: 3 Key Developments To Watch In Q2 Earnings
Holdings has accelerated revenue growth and expanded gross margins. Read what supports a compelling long-term investment ...
Zacks Investment Research on MSN1d
Here's Why Moderna (MRNA) Fell More Than Broader Market
Moderna (MRNA) ended the recent trading session at $31.25, demonstrating a -2.95% change from the preceding day's closing price. This move lagged the S&P 500's daily loss of 0.01%. Elsewhere, the Dow ...
Amex Q2 results prove it’s still the heavyweight of high-end cards
The credit card company just beat profit expectations in its second quarter earnings, a feat powered by strong spending that ...
Zacks Investment Research on MSN2d
Molina to Report Q2 Earnings: Healthy Revenues, Weak Pulse on Earnings
Healthcare plan provider, Molina Healthcare, Inc. MOH, is set to report second-quarter 2025 results on July 23, 2025, after ...
Novartis Q2 Earnings Review: Solid Results Justify All-Time High Share Price
Novartis AG beats Q2 2025 expectations, but patent expiries and policy risks loom. Click for my updated look at NVS earnings ...
IBM and Moderna Team Up on Quantum Study. What It Means for the World of Medicine.
International Business Machines said Thursday that it had joined forces with Moderna for a case study that evidenced quantum ...
Novartis3d
Novartis reports strong Q2 with double-digit sales growth and core margin expansion; raises FY 2025 core operating income guidance
Sales growth driven by continued strong performance from Kisqali (+64% cc), Entresto (+22% cc), Kesimpta (+33% cc), Scemblix (+79% cc), Leqvio (+61% cc) and Pluvicto (+30% cc) Core operating income ...